Interested in specific type?

Filter what you see here

FLT3

Assoc. Prof. Jessica K. Altman | 2017 ASCO Annual Meeting | Molecular response to gilteritinib, a FLT3 inhibitor, in R/R AML, FLT3+

, Jun 8, 2017 , Expert Opinion

L:

2017 ASCO Annual Meeting - 2-6 June, Chicago    

Related articles

Prof. Tapan M. Kadia | 2017 ASCO Annual Meeting | Highlights of the oral session on AML

Jun 8, 2017

Orphan Drug Designation granted for gilteritinib in Japan for the treatment of FLT3 mutated AML

Mar 23, 2018

Prof. Charles Craddock | EBMT 2018 | Can hypomethylating agents prevent post-transplant relapse in AML?

Mar 23, 2018